Beta-(1,3/1,6)-D-glucan Helps to Decrease Opportunistic Infections in Crohn's Disease Patients Treated with Biological Therapy
Journal: Archives of Clinical Gastroenterology (Vol.1, No. 1)Publication Date: 2015-08-28
Authors : Batovsky Marian Zamborsky Tomas Radwan Khaled Desatova Barbora; Kadleckova Barbora;
Page : 005-008
Keywords : Crohn's disease; Beta-glucan; Clinical trial; Maintenance therapy;
Abstract
Background: Secondary intercurrent infections in patients with inflammatory bowel disease (IBD) represent a very important problem in daily clinical practice because of their significant contribution to quality of life and work ability. Beta-glucans are known to act as non-specific immunomodulators that exhibit an anti-inflammatory effect as evident in animal and human studies. Imunoglukan P4H® capsules are nutritional supplement containing 100 mg of beta-(1,3/1,6)-D-glucan pleuran isolated from oyster mushroom Pleurotus ostreatus and 100 mg of vitamin C.
Other Latest Articles
- Implementation and Implication of Ignoring Small Polyps at Colonoscopy
- Retrograde Amnesia and Disorientation after Intraocular Injection of Anti-VEGF Agents
- Vitamin -D Deficiency: A Clinical Problem Searching For Solution
- Assessment of Biofield Energy Healing Based Vitamin D3 Effects on Bone Health Parameters Using Human Osteoblast Cell Line (MG-63)
- Safety, Tolerability, Efficacy and Logistics of Administration of Three Types of Therapeutic Feeds to Children with Severe Acute Malnutrition (SAM)
Last modified: 2018-09-04 14:03:30